Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
biotech
fda
alnylam pharmaceuticals
astrazeneca
avexis
brian kaspar
bristol-myers squibb
centers for disease control and prevention
eli lilly
gene therapy
What
roundup
4
×
bio
biotech
news
according
advantages
akcea
alzheimer’s
august
bar
brings
busy
cases
centers
cigarettes
congress
control
days
deaths
decisions
democrats
devices
disease
divided
drug
drugs
elections
electronic
expect
fallout
fda
gamble
including
injuries
legacy
linked
losses
lung
market
medco’s
Language
unset
Current search:
amgen
×
roundup
×
novartis
×
" clinical trials "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
